...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
Reply New Message
Back To Forum List View
Icon president Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
2
BearDownAZ
Jan 13, 2020 08:29AM
Icon president Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
4
BearDownAZ
Jan 13, 2020 08:32AM
Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
2
Cabel
Jan 13, 2020 08:40AM

Correction: "BETonMACE Results Show 57% Hazard Reduction in Primary MACE for Patients on Apabetalone and New Oral Anti-Diabetic Treatments"

Previous version stated "BETonMACE Results Show 57% Hazard Reduction in Primary MACE for Patients on Apabetalone and New Oral"

 

1 Recommendations
Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
4
paladin
Jan 13, 2020 09:24AM
Re: Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
3
Cabel
Jan 13, 2020 09:57AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply